Minerva Neurosciences (NERV) Share-based Compensation (2014 - 2026)

Minerva Neurosciences has reported Share-based Compensation for 13 years, with the latest figure at $8.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 2830.5% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (up 722.74% YoY), and the FY2025 full-year result was $1.3 million, changed 0.14% from the prior year.
• Share-based Compensation for Q1 2026 stood at $8.7 million, up from $459028.0 in the prior quarter.
• The five-year high for Share-based Compensation was $8.7 million in Q1 2026, with the low at $249650.0 in Q4 2024.
• Historically, Share-based Compensation has averaged $1.0 million across 5 years, with a median of $438849.0 in 2024.
• Annual changes were most pronounced in 2023 — Share-based Compensation slumped 64.24% — and 2026, when it jumped 2830.5%.
• Minerva Neurosciences' Share-based Compensation stood at $947684.0 in 2022, then plunged by 35.52% to $611064.0 in 2023, then plunged by 59.15% to $249650.0 in 2024, then soared by 83.87% to $459028.0 in 2025, then jumped by 1797.55% to $8.7 million in 2026.
• The last three Share-based Compensation figures came in at $8.7 million (Q1 2026), $459028.0 (Q4 2025), and $272897.0 (Q3 2025), per Business Quant data.